trending Market Intelligence /marketintelligence/en/news-insights/trending/729Vq35lFznicluxQzh1zA2 content esgSubNav
In This List

Eleven Biotherapeutics plans common stock offering

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Eleven Biotherapeutics plans common stock offering

Eleven Biotherapeutics Inc. plans to offer $12.5 million of its common stock.

The company plans to use the net proceeds to continue funding the clinical development of Vicinium and for general corporate purposes, which may include capital expenditures and funding our working capital needs.

H.C. Wainwright & Co. LLC will act as the sole book-running manager for this offering.